New concepts in understanding genital herpes

Current Infectious Disease Reports

Volumn 11, Issue 6, 2009, Pages 457-464

  Schiffer, Joshua T ^a   Corey, Lawrence ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CIDOFOVIR; FAMCICLOVIR; FOSCARNET; HERPES SIMPLEX VACCINE; NUCLEOSIDE ANALOG; VALACICLOVIR;

ANTIVIRAL RESISTANCE; CHILL; CLINICAL FEATURE; CLINICAL TRIAL; CONDOM; DRUG EFFICACY; DRUG ERUPTION; GENITAL HERPES; GENITAL ULCER; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INCIDENCE; INFECTION PREVENTION; KIDNEY FAILURE; LABORATORY DIAGNOSIS; NAUSEA; NEPHROTOXICITY; NONHUMAN; PREGNANCY; PREVALENCE; RECURRENCE RISK; REVIEW; SEXUAL TRANSMISSION; UNSPECIFIED SIDE EFFECT; VACCINATION; VIRUS IMMUNITY; VIRUS PATHOGENESIS; VIRUS REACTIVATION; VIRUS SHEDDING; VIRUS TRANSMISSION; WASTING SYNDROME;

EID: 70449484478     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-009-0066-7     Document Type: Review

References (56)

1. F. Xu M. Sternberg B. Kottiri, et al. 2006 Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States JAMA 296 964 973 10.1001/jama.296.8.964 1:CAS:528:DC%2BD28Xoslyiu7w%3D 16926356 (Pubitemid 44285373)
2. A.G. Langenberg L. Corey R.L. Ashley, et al. 1999 A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group N Engl J Med 341 1432 1438 10.1056/NEJM199911043411904 1:STN:280:DC%2BD3c%2FgtFyktw%3D%3D 10547406 (Pubitemid 29513459)
3. A. Wald J. Zeh S. Selke, et al. 2000 Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons N Engl J Med 342 844 850 10.1056/NEJM200003233421203 1:STN:280:DC%2BD3c7ntVGitg%3D%3D 10727588 (Pubitemid 30165207)
4. K.E. Mark A. Wald A.S. Magaret, et al. 2008 Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults J Infect Dis 198 1141 1149 10.1086/591913 18783315
5. A. Wald J. Zeh G. Barnum L. Davis L. Corey 1996 Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir Ann Intern Med 1241Pt1 8 15
6. G.J. Mertz O. Schmidt J.L. Jourden, et al. 1985 Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts Sex Transm Dis 12 33 39 1:STN:280: DyaL2M3hvFWgtA%3D%3D 2988143
7. J. Zhu D. Koelle J. Cao, et al. 2007 Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation J Exp Med 204 595 603 10.1084/jem.20061792 1:CAS:528: DC%2BD2sXjsVyqsrw%3D 17325200 (Pubitemid 46457082)
8. E. Freeman H. Weiss J. Glynn, et al. 2006 Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies AIDS 20 73 83 10.1097/01.aids.0000198081. 09337.a7 16327322
9. R. Gray M. Wawer R. Brookmeyer, et al. 2001 Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda Lancet 357 1149 1153 10.1016/S0140-6736(00)04331-2 1:STN:280:DC%2BD3MzisFejug%3D%3D 11323041 (Pubitemid 32378686)
10. L. Corey J. Benedetti C. Critchlow, et al. 1983 Treatment of primary first-episode genital herpes simplex virus infections with acyclovir: results of topical, intravenous and oral therapy J Antimicrob Chemother 12SupplB 79 88
11. J.M. Douglas C. Critchlow J. Benedetti, et al. 1984 A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection N Engl J Med 310 1551 1556 1:STN:280:DyaL2c3hvFGksw%3D%3D 6328298 (Pubitemid 14117334)
12. L. Corey A. Wald R. Patel, et al. 2004 Once-daily valacyclovir to reduce the risk of transmission of genital herpes N Engl J Med 350 11 20 10.1056/NEJMoa035144 1:CAS:528:DC%2BD2cXhtFGitg%3D%3D 14702423 (Pubitemid 38032179)
13. A. Wald A. Langenberg E. Krantz, et al. 2005 The relationship between condom use and herpes simplex virus acquisition Ann Intern Med 143 707 713 16287791
14. A. Wald A. Langenberg K. Link, et al. 2001 Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women JAMA 285 3100 3106 10.1001/jama.285.24.3100 1:STN:280:DC%2BD3Mzotl2qug%3D%3D 11427138
15. H. Weiss 2004 Epidemiology of herpes simplex virus type 2 infection in the developing world Herpes 11Suppl1 24A 35A
16. A.J. Vyse N.J. Gay M.J. Slomka, et al. 2000 The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes Sex Transm Infect 76 183 187 10.1136/sti.76.3.183 1:STN:280:DC%2BD3cvhvVymuw%3D%3D 10961195 (Pubitemid 30435200)
17. T.L. Cherpes L.A. Meyn M.A. Krohn S.L. Hillier 2003 Risk factors for infection with herpes simplex virus type 2: role of smoking, douching, uncircumcised males, and vaginal flora Sex Transm Dis 30 405 410 10.1097/00007435-200305000-00006 12916131 (Pubitemid 36605489)
18. S. Gottlieb J.J. Douglas M. Foster, et al. 2004 Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling J Infect Dis 190 1059 1067 10.1086/423323 15319854 (Pubitemid 39186791)
19. E. Brown A. Wald J. Hughes, et al. 2006 High risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study Am J Epidemiol 164 733 741 10.1093/aje/kwj270 1:STN:280:DC%2BD28rotVWqsw%3D%3D 16896053 (Pubitemid 44522078)
20. L.R. Stanberry S.L. Spruance A.L. Cunningham, et al. 2002 Glycoprotein-D-adjuvant vaccine to prevent genital herpes N Engl J Med 347 1652 1661 10.1056/NEJMoa011915 1:CAS:528:DC%2BD38XovFSisr0%3D 12444179 (Pubitemid 35340783)
21. A. Wald M.L. Huang D. Carrell, et al. 2003 Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture J Infect Dis 188 1345 1351 10.1086/379043 1:CAS:528:DC%2BD3sXpsl2kuro%3D 14593592 (Pubitemid 37433705)
22. Z.A. Brown J. Benedetti R. Ashley, et al. 1991 Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor N Engl J Med 324 1247 1252 1:STN:280:DyaK3M7psVOgsg%3D%3D 1849612
23. K. Wang T. Lau M. Morales, et al. 2005 Laser-capture microdis-section: refining estimates of the quantity and distribution of latent herpes simplex virus 1 and varicella-zoster virus DNA in human trigeminal ganglia at the single-cell level J Virol 79 14079 14087 10.1128/JVI.79.22.14079-14087.2005 1:CAS:528:DC%2BD2MXht1ShsLvM 16254342 (Pubitemid 41552705)
24. C. Johnston A. Magaret S. Selke, et al. 2008 Herpes simplex virus viremia during primary genital infection J Infect Dis 198 31 34 10.1086/588676 18471083 (Pubitemid 351920286)
25. T. Liu K. Khanna B. Carriere R. Hendricks 2001 Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons J Virol 75 11178 11184 10.1128/JVI.75.22.11178-11184.2001 1:CAS:528: DC%2BD3MXnvVelur4%3D 11602757 (Pubitemid 33031584)
26. C. Crespi W. Cumberland A. Wald, et al. 2007 Longitudinal study of herpes simplex virus type 2 infection using viral dynamic modelling Sex Transm Infect 83 359 364 10.1136/sti.2006.022020 17475687 (Pubitemid 47242482)
27. D. Koelle Z. Liu C. McClurkan, et al. 2002 Expression of cutaneous lymphocyte-associated antigen by CD8(+) T cells specific for a skin-tropic virus J Clin Invest 110 537 548 1:CAS:528:DC%2BD38XmsVSiu7o%3D 12189248
28. J. Zhu F. Hladik A. Woodward, et al. 2009 Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition Nat Med 15 886 892 10.1038/nm.2006 1:CAS:528:DC%2BD1MXpt1Ogs7s%3D 19648930
29. D. Bernstein M. Lovett Y. Bryson 1984 Serologic analysis of first-episode nonprimary genital herpes simplex virus infection. Presence of type 2 antibody in acute serum samples Am J Med 77 1055 1060 10.1016/0002-9343(84)90188-8 1:STN:280:DyaL2M%2FmvFGhtQ%3D%3D 6507459 (Pubitemid 15221769)
30. L. Corey H.G. Adams Z.A. Brown K.K. Holmes 1983 Genital herpes simplex virus infections: clinical manifestations, course, and complications Ann Intern Med 98 958 972 1:STN:280:DyaL3s3ivFamsA%3D%3D 6344712
31. S.E. Goodell T.C. Quinn E. Mkrtichian, et al. 1983 Herpes simplex virus proctitis in homosexual men. Clinical, sigmoidoscopic, and histopathological features N Engl J Med 308 868 871 1:STN:280:DyaL3s7mslaqsg%3D%3D 6300674
32. J. Benedetti L. Corey R. Ashley 1994 Recurrence rates in genital herpes after symptomatic first-episode infection Ann Intern Med 121 847 954 1:STN:280:DyaK2M%2FmvFeqsg%3D%3D 7978697
33. R. Engelberg D. Carrell E. Krantz, et al. 2003 Natural history of genital herpes simplex virus type 1 infection Sex Transm Dis 30 174 177 10.1097/00007435-200302000-00015 12567178 (Pubitemid 36184367)
34. Y. Schlesinger P. Tebas M. Gaudreault-Keener, et al. 1995 Herpes simplex virus type 2 meningitis in the absence of genital lesions: improved recognition with use of the polymerase chain reaction Clin Infect Dis 20 842 848 1:STN:280:DyaK2MzhsFertw%3D%3D 7795083
35. T.J. Liesegang L.J. Melton 3rd P.J. Daly D.M. Ilstrup 1989 Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982 Arch Ophthalmol 107 1155 1159 1:STN:280:DyaL1MzjsVKlsg%3D%3D 2787981
36. S.A. Morse D.L. Trees Y. Htun, et al. 1997 Comparison of clinical diagnosis and standard laboratory and molecular methods for the diagnosis of genital ulcer disease in Lesotho: association with human immunodeficiency virus infection J Infect Dis 175 583 589 1:STN:280:DyaK2s7ptlOntg%3D%3D 9041329
37. T.B. Martins R.D. Woolstenhulme T.D. Jaskowski, et al. 2001 Comparison of four enzyme immunoassays with a western blot assay for the determination of type-specific antibodies to herpes simplex virus Am J Clin Pathol 115 272 277 10.1309/RV29-7CCN-5DYW-M4Y6 1:CAS:528:DC%2BD3MXhtFKgsL0%3D 11211617 (Pubitemid 32150687)
38. US Centers for Disease Control and Prevention: Diseases characterized by genital ulcers. Available at http://www.cdc.gov/std/treatment/2006/genital- ulcers.htm#genulc3. Accessed June 2009.
39. S. Safrin C. Crumpacker P. Chatis, et al. 1991 A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group N Engl J Med 325 551 555 1:STN:280:DyaK3Mzht1CjtA%3D%3D 1649971
40. D.B. Mendel D.B. Barkhimer M.S. Chen 1995 Biochemical basis for increased susceptibility to Cidofovir of herpes simplex viruses with altered or deficient thymidine kinase activity Antimicrob Agents Chemother 39 2120 2122 1:CAS:528:DyaK2MXnvVygt7k%3D 8540727
41. A. Wald E. Krantz S. Selke, et al. 2006 Knowledge of partners' genital herpes protects against herpes simplex virus type 2 acquisition J Infect Dis 194 42 52 10.1086/504717 16741881 (Pubitemid 43911924)
42. T. Kobbermann L. Clark W.T. Griffin 1980 Maternal death secondary to disseminated herpesvirus hominis Am J Obstet Gynecol 137 742 743 1:STN:280:DyaL3c3jvFKjtQ%3D%3D 7395942
43. R.J. Whitley A.J. Nahmias A.M. Visintine, et al. 1980 The natural history of herpes simplex virus infection of mother and newborn Pediatrics 66 489 494 1:STN:280:DyaL3M%2FltlaktQ%3D%3D 6253866
44. Z.A. Brown S. Selke J. Zeh, et al. 1997 The acquisition of herpes simplex virus during pregnancy N Engl J Med 337 509 515 10.1056/NEJM199708213370801 1:STN:280:DyaK2szptVWquw%3D%3D 9262493 (Pubitemid 27352016)
45. R. Kropp T. Wong L. Cormier, et al. 2006 Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study Pediatrics 117 1955 1962 10.1542/peds.2005-1778 16740836 (Pubitemid 46071239)
46. E.L. Brown C. Gardella G. Malm, et al. 2007 Effect of maternal herpes simplex virus (HSV) serostatus and HSV type on risk of neonatal herpes Acta Obstet Gynecol Scand 86 523 529 10.1080/00016340601151949 17464578 (Pubitemid 46676310)
47. L. Abu-Raddad A. Magaret C. Celum, et al. 2008 Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa PLoS ONE 3 e2230 10.1371/journal.pone.0002230 18493617
48. M. Morris M. Kretzschmar 1997 Concurrent partnerships and the spread of HIV AIDS 11 641 648 10.1097/00002030-199705000-00012 1:STN:280: DyaK2s3mt1KlsA%3D%3D 9108946 (Pubitemid 27135886)
49. A. Drake G. John-Stewart A. Wald, et al. 2007 Herpes simplex virus type 2 and risk of intrapartum human immunodeficiency virus transmission Obstet Gynecol 1092Pt1 403 409 (Pubitemid 46197434)
50. T. Schacker J. Zeh H. Hu, et al. 2002 Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression J Infect Dis 186 1718 1725 10.1086/345771 12447756 (Pubitemid 35463503)
51. N. Nagot A. Ouédraogo V. Foulongne, et al. 2007 Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus N Engl J Med 356 790 799 10.1056/NEJMoa062607 1:CAS:528:DC%2BD2sXhvFKltLo%3D 17314338 (Pubitemid 46294611)
52. C. Celum A. Wald J. Hughes, et al. 2008 Effect of acyclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial Lancet 371 2109 2119 10.1016/S0140-6736(08)60920-4 1:CAS:528:DC%2BD1cXnsFGjurY%3D 18572080 (Pubitemid 351902179)
53. D. Watson-Jones H.A. Weiss M. Rusizoka, et al. 2008 Effect of herpes simplex suppression on incidence of HIV among women in Tanzania N Engl J Med 358 1560 1571 10.1056/NEJMoa0800260 1:CAS:528:DC%2BD1cXksF2hs7w%3D 18337596
54. Celum C, Wald A, Lingappa J, et al.: Twice-daily acyclovir to reduce HIV-1 transmission from HIV-1 / HSV-2 co-infected persons within HIV-1 serodiscordant couples: a randomized, double-blind, placebo-controlled trial [abstract WELBC101]. Presented at the Fifth International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention. Cape Town, South Africa; July 19-22, 2009.
55. A. Lisco C. Vanpouille E.P. Tchesnokov, et al. 2008 Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues Cell Host Microbe 4 260 270 10.1016/j.chom.2008.07.008 1:CAS:528:DC%2BD1cXhtF2jt7jI 18779052
56. M.A. McMahon J.D. Siliciano J. Lai, et al. 2008 The antiherpetic drug acyclovir inhibits HIV replication and selects the V75I reverse transcriptase multidrug resistance mutation J Biol Chem 283 31289 31293 10.1074/jbc.C800188200 1:CAS:528:DC%2BD1cXhtlCjsLfJ 18818198